JNJ: Johnson & Johnson Stocks News on November 27, 2025

Is Kenvue’s Share Price a Bargain After 13.5% Jump and New Product Launches?

JNJ

Simply Wall St.

a day ago

Is Kenvue’s Share Price a Bargain After 13.5% Jump and New Product Launches?

Johnson & Johnson (JNJ): Exploring Valuation Perspectives After Recent Share Price Momentum

JNJ

Simply Wall St.

a day ago

Johnson & Johnson (JNJ): Exploring Valuation Perspectives After Recent Share Price Momentum

BMY Wins EC Nod for Label Expansion of CAR T Cell Therapy Breyanzi

JNJ

Zacks

2 days ago

BMY Wins EC Nod for Label Expansion of CAR T Cell Therapy Breyanzi

J&J Up Around 17% in 3 Months: Should You Buy, Sell or Hold the Stock?

JNJ

Zacks

2 days ago

J&J Up Around 17% in 3 Months: Should You Buy, Sell or Hold the Stock?

Bayer Resurrects Scrapped Blood-Thinning Drug as Breakthrough Stroke Treatment

JNJ

The Daily Upside

2 days ago

Bayer Resurrects Scrapped Blood-Thinning Drug as Breakthrough Stroke Treatment

4 takeaways from pharma’s manufacturing boom

JNJ

Pharma Voice

2 days ago

4 takeaways from pharma’s manufacturing boom

If You Invested $10K In Johnson & Johnson Stock 10 Years Ago, How Much Would You Have Now?

JNJ

Benzinga

2 days ago

If You Invested $10K In Johnson & Johnson Stock 10 Years Ago, How Much Would You Have Now?

Nanobiotix Provides Third Quarter 2025 Operational and Financial Update Along With 2026 Clinical Outlook

JNJ

GlobeNewswire

3 days ago

Nanobiotix Provides Third Quarter 2025 Operational and Financial Update Along With 2026 Clinical Outlook

BAYRYs Cardiovascular Drug Hits Goals in Late-Stage Study

JNJ

Zacks

3 days ago

BAYRYs Cardiovascular Drug Hits Goals in Late-Stage Study

EXCLUSIVE: Sustainable Value Creation: Keynote Fireside with Trian Fund Management, 5th Palm Beach CorpGov Forum

JNJ

CorpGov.com

3 days ago

EXCLUSIVE: Sustainable Value Creation: Keynote Fireside with Trian Fund Management, 5th Palm Beach CorpGov Forum

Hip Replacement Market Competitive Landscape Report 2025: Recent Developments, Strategies, Sustainability, Product Launches, Key Persons, and Revenue Forecasts

JNJ

GlobeNewswire

3 days ago

Hip Replacement Market Competitive Landscape Report 2025: Recent Developments, Strategies, Sustainability, Product Launches, Key Persons, and Revenue Forecasts

Biotech Stock Nanobiotix (NBTX) Is Up 660% This Year -- Here's Why the Rally Could Continue

JNJ

Motley Fool

3 days ago

Biotech Stock Nanobiotix (NBTX) Is Up 660% This Year -- Here's Why the Rally Could Continue

JNJ

Argus Research

3 days ago

Weekly Stock List

RVL Pharmaceuticals Announces Leadership Appointments to Accelerate Next Phase of Growth and Commercial Momentum

JNJ

PR Newswire

3 days ago

RVL Pharmaceuticals Announces Leadership Appointments to Accelerate Next Phase of Growth and Commercial Momentum

Jim Cramer Dissects Kimberly-Clark’s Acquisition of Kenvue

JNJ

Insider Monkey

4 days ago

Jim Cramer Dissects Kimberly-Clark’s Acquisition of Kenvue

Jim Cramer on Kenvue: “I Think It is a Good Situation, Not a Bad One”

JNJ

Insider Monkey

5 days ago

Jim Cramer on Kenvue: “I Think It is a Good Situation, Not a Bad One”

How Recent Developments Are Rewriting the Story for Johnson & Johnson

JNJ

Simply Wall St.

5 days ago

How Recent Developments Are Rewriting the Story for Johnson & Johnson

Contineum’s MS drug falls short in Phase II trial

JNJ

Clinical Trials Arena

6 days ago

Contineum’s MS drug falls short in Phase II trial

1 Reason Why Shares of Johnson & Johnson Are Surging This Month

JNJ

Motley Fool

6 days ago

1 Reason Why Shares of Johnson & Johnson Are Surging This Month

Eli Lilly Reaches $1 Trillion Market Cap on Booming Weight-Loss Drugs

JNJ

The Wall Street Journal

6 days ago

Eli Lilly Reaches $1 Trillion Market Cap on Booming Weight-Loss Drugs

Healthcare ETFs to Buy as Big Pharma Rapidly Integrates AI

JNJ

Zacks

6 days ago

Healthcare ETFs to Buy as Big Pharma Rapidly Integrates AI

This Medical Technology Leader Sees Profit Growth Topping 44%

JNJ

Investor's Business Daily

6 days ago

This Medical Technology Leader Sees Profit Growth Topping 44%

Hologic's GYN Surgical Delivers a Standout Quarter: What's Behind It?

JNJ

Zacks

6 days ago

Hologic's GYN Surgical Delivers a Standout Quarter: What's Behind It?

Surgical Stapling Devices Market Analysis Report 2025: Disposable Surgical Stapling Devices Lead Expansion Amid Rising Demand for Minimally Invasive Procedures - Global Forecast to 2029

JNJ

GlobeNewswire

6 days ago

Surgical Stapling Devices Market Analysis Report 2025: Disposable Surgical Stapling Devices Lead Expansion Amid Rising Demand for Minimally Invasive Procedures - Global Forecast to 2029

Will Librexia ACS Study Setback Dent BMY's Cardiovascular Portfolio?

JNJ

Zacks

7 days ago

Will Librexia ACS Study Setback Dent BMY's Cardiovascular Portfolio?

OMP Miami Conference 2025: Transforming Supply Chain Vision into REAL Impact with Human-AI Synergy

JNJ

ACCESS Newswire

7 days ago

OMP Miami Conference 2025: Transforming Supply Chain Vision into REAL Impact with Human-AI Synergy

Beyond GLP-1: Eli Lilly's Expanding Drug Portfolio Lifts Sales

JNJ

Zacks

7 days ago

Beyond GLP-1: Eli Lilly's Expanding Drug Portfolio Lifts Sales

Clarity Eye Centre Brings SILK™ Laser Eye Technology to Hong Kong

JNJ

PR Newswire

7 days ago

Clarity Eye Centre Brings SILK™ Laser Eye Technology to Hong Kong

JNJ

MT Newswires

8 days ago

Sector Update: Health Care Stocks Softer Late Afternoon

JNJ

MT Newswires

8 days ago

Sector Update: Health Care

JNJ

MT Newswires

8 days ago

Johnson & Johnson's Janssen Gets FDA Approval for Darzalex in Amyloidosis

Why big pharma is teaming up with AI giants to speed up drug discovery and make work easier for health care workers

JNJ

Fortune

8 days ago

Why big pharma is teaming up with AI giants to speed up drug discovery and make work easier for health care workers

Why Johnson & Johnson's Share Price Is Popping This Month

JNJ

Motley Fool

8 days ago

Why Johnson & Johnson's Share Price Is Popping This Month

Merck Stock Rise as New PAH Drug Winrevair Meets Goal in Another Study

JNJ

Zacks

8 days ago

Merck Stock Rise as New PAH Drug Winrevair Meets Goal in Another Study

Knee Replacement Surgery Market Analysis Report 2025-2035: Stryker, Zimmer Biomet, B. Braun, and DePuy Synthes Lead Innovations by Continually Innovating and Improving Patient Outcomes

JNJ

GlobeNewswire

8 days ago

Knee Replacement Surgery Market Analysis Report 2025-2035: Stryker, Zimmer Biomet, B. Braun, and DePuy Synthes Lead Innovations by Continually Innovating and Improving Patient Outcomes

Why Johnson & Johnson (JNJ) Is Up 5.9% After Multiple FDA Approvals and Positive Drug Trial Results

JNJ

Simply Wall St.

8 days ago

Why Johnson & Johnson (JNJ) Is Up 5.9% After Multiple FDA Approvals and Positive Drug Trial Results

J&J Joins Pharma M&A Bandwagon, to Buy Cancer Biotech for $3.05B

JNJ

Zacks

9 days ago

J&J Joins Pharma M&A Bandwagon, to Buy Cancer Biotech for $3.05B

Here's How Neuroscience Drugs Aided AbbVie's Top-line Growth in Q3

JNJ

Zacks

9 days ago

Here's How Neuroscience Drugs Aided AbbVie's Top-line Growth in Q3

Johnson & Johnson Buys Prostate Cancer Treatment-Maker Halda for $3.1 Billion

JNJ

The Daily Upside

9 days ago

Johnson & Johnson Buys Prostate Cancer Treatment-Maker Halda for $3.1 Billion

Johnson & Johnson to acquire Halda Therapeutics for $3.05bn

JNJ

Pharmaceutical Technology

9 days ago

Johnson & Johnson to acquire Halda Therapeutics for $3.05bn

JNJ

Zacks

9 days ago

The Zacks Analyst Blog Highlights Eli Lilly, Johnson & Johnson and Adverum

Johnson & Johnson Expands Oncology Pipeline with $3.05 Billion Halda Acquisition

JNJ

GuruFocus.com

9 days ago

Johnson & Johnson Expands Oncology Pipeline with $3.05 Billion Halda Acquisition

Stock Market Today: Dow Skids, AI Play Dives As Peter Thiel Exits; Netflix Divvies Up Its Shares (Live Coverage)

JNJ

Investor's Business Daily

10 days ago

Stock Market Today: Dow Skids, AI Play Dives As Peter Thiel Exits; Netflix Divvies Up Its Shares (Live Coverage)

JNJ

MT Newswires

10 days ago

Sector Update: Health Care Stocks Softer Late Afternoon

Johnson & Johnson Will Buy Cancer Drugmaker Halda Therapeutics for $3.1 Billion

JNJ

Barrons.com

10 days ago

Johnson & Johnson Will Buy Cancer Drugmaker Halda Therapeutics for $3.1 Billion

JNJ

MT Newswires

10 days ago

Sector Update: Health Care

Johnson & Johnson Inks A $3.05 Billion Deal In Cancer Treatment

JNJ

Investor's Business Daily

10 days ago

Johnson & Johnson Inks A $3.05 Billion Deal In Cancer Treatment

JNJ

MT Newswires

10 days ago

Johnson & Johnson to Buy Halda Therapeutics for $3.05 Billion in Cash

Halda Therapeutics Announces Acquisition by Johnson & Johnson

JNJ

GlobeNewswire

10 days ago

Halda Therapeutics Announces Acquisition by Johnson & Johnson

New long-term data reinforces TREMFYA® (guselkumab) as the only IL-23 inhibitor proven to substantially inhibit structural joint damage in active psoriatic arthritis

JNJ

PR Newswire

10 days ago

New long-term data reinforces TREMFYA® (guselkumab) as the only IL-23 inhibitor proven to substantially inhibit structural joint damage in active psoriatic arthritis

Johnson & Johnson Set to Revolutionize the Treatment of Cancer With the Acquisition of Halda Therapeutics

JNJ

Business Wire

10 days ago

Johnson & Johnson Set to Revolutionize the Treatment of Cancer With the Acquisition of Halda Therapeutics

Growth or Stability? A 2025 Investment Face-Off Between LLY and JNJ

JNJ

Zacks

10 days ago

Growth or Stability? A 2025 Investment Face-Off Between LLY and JNJ

Johnson & Johnson (JNJ) Emerges as Scotiabank’s Top Pick for Curative Treatments

JNJ

Insider Monkey

11 days ago

Johnson & Johnson (JNJ) Emerges as Scotiabank’s Top Pick for Curative Treatments

Bristol Myers Slouches 4% After Experts Say Its Heart Drug Will Fail

JNJ

Investor's Business Daily

13 days ago

Bristol Myers Slouches 4% After Experts Say Its Heart Drug Will Fail

JNJ

MT Newswires

13 days ago

Sector Update: Health Care Stocks Ease Late Afternoon

JNJ

MT Newswires

13 days ago

US Equity Indexes Mixed Amid Technology Rebound

JNJ

MT Newswires

13 days ago

Sector Update: Health Care Stocks Fall Friday Afternoon

JNJ

MT Newswires

13 days ago

US Equity Indexes Mixed as Technology Rebound Helps Lift Nasdaq, S&P 500

How Recent Moves Are Rewriting the Story for Pfizer

JNJ

Simply Wall St.

13 days ago

How Recent Moves Are Rewriting the Story for Pfizer

JNJ

MT Newswires

13 days ago

Sector Update: Health Care

Bristol Myers Shares Sink on Yet Another Trial Failure

JNJ

Barrons.com

13 days ago

Bristol Myers Shares Sink on Yet Another Trial Failure

JNJ

MT Newswires

13 days ago

Market Chatter: Judge to Decide on Texas AG's Bid to Block Kenvue's Dividend

Bristol Myers Slumps After Its Heart Condition Study Gets The Boot

JNJ

Investor's Business Daily

13 days ago

Bristol Myers Slumps After Its Heart Condition Study Gets The Boot

JNJ

MT Newswires

13 days ago

Sector Update: Health Care Stocks Decline Premarket Friday

JNJ

MT Newswires

13 days ago

Sector Update: Health Care

Pharma ETFs in Spotlight Following Robust Q3 Earnings Results

JNJ

Zacks

13 days ago

Pharma ETFs in Spotlight Following Robust Q3 Earnings Results

JNJ

Business Wire

13 days ago

Update on Phase 3 Librexia ACS Trial

JNJ

Insider Monkey

14 days ago

Jim Cramer Shows Confidence in Amgen

Jim Cramer Notes Johnson & Johnson is “Really Bearing Down on High-Growth Pharma”

JNJ

Insider Monkey

14 days ago

Jim Cramer Notes Johnson & Johnson is “Really Bearing Down on High-Growth Pharma”

Nike upgraded, Dollar Tree downgraded: Wall Street's top analyst calls

JNJ

The Fly

14 days ago

Nike upgraded, Dollar Tree downgraded: Wall Street's top analyst calls

Shine a Light on Healthcare ETFs Amid National Alzheimer's Awareness Month

JNJ

Zacks

14 days ago

Shine a Light on Healthcare ETFs Amid National Alzheimer's Awareness Month

JNJ

MT Newswires

14 days ago

Scotiabank Initiates Johnson & Johnson at Sector Outperform With $230 Price Target

2 Healthcare Stocks for Beginner Investors With a 40-Year Time Horizon

JNJ

Motley Fool

14 days ago

2 Healthcare Stocks for Beginner Investors With a 40-Year Time Horizon

2 Strong Healthcare Stock Picks for Dividend Investors

JNJ

Motley Fool

14 days ago

2 Strong Healthcare Stock Picks for Dividend Investors

BeOne, IBD Stock Of The Day, Breaks Out As It Takes On Cancer Giants J&J, AbbVie

JNJ

Investor's Business Daily

15 days ago

BeOne, IBD Stock Of The Day, Breaks Out As It Takes On Cancer Giants J&J, AbbVie

Walt Disney and 15 More Non-AI Stocks Worth a Look

JNJ

Barrons.com

15 days ago

Walt Disney and 15 More Non-AI Stocks Worth a Look

Bayer Q3 Earnings Beat Estimates on Crop Science Business Gains

JNJ

Zacks

15 days ago

Bayer Q3 Earnings Beat Estimates on Crop Science Business Gains

J&J's MedTech Unit Sales Improve: Will the Momentum Last?

JNJ

Zacks

15 days ago

J&J's MedTech Unit Sales Improve: Will the Momentum Last?

Assessing Johnson & Johnson's Value After Medtech Acquisition and 34.6% Year-to-Date Surge

JNJ

Simply Wall St.

15 days ago

Assessing Johnson & Johnson's Value After Medtech Acquisition and 34.6% Year-to-Date Surge

Lantheus, Enovis, Evolent Health, Repligen, and Corcept Shares Are Soaring, What You Need To Know

JNJ

StockStory

16 days ago

Lantheus, Enovis, Evolent Health, Repligen, and Corcept Shares Are Soaring, What You Need To Know

Merck, Elanco, Myriad Genetics, Neogen, and Cigna Shares Are Soaring, What You Need To Know

JNJ

StockStory

16 days ago

Merck, Elanco, Myriad Genetics, Neogen, and Cigna Shares Are Soaring, What You Need To Know

Gilead Sciences, Moderna, Artivion, Tenet Healthcare, and Charles River Laboratories Stocks Trade Up, What You Need To Know

JNJ

StockStory

16 days ago

Gilead Sciences, Moderna, Artivion, Tenet Healthcare, and Charles River Laboratories Stocks Trade Up, What You Need To Know

Viatris, Oscar Health, BioMarin Pharmaceutical, QuidelOrtho, and Bausch + Lomb Stocks Trade Up, What You Need To Know

JNJ

StockStory

16 days ago

Viatris, Oscar Health, BioMarin Pharmaceutical, QuidelOrtho, and Bausch + Lomb Stocks Trade Up, What You Need To Know

Elevance Health, Labcorp, Privia Health, Fortrea, and Amgen Shares Are Soaring, What You Need To Know

JNJ

StockStory

16 days ago

Elevance Health, Labcorp, Privia Health, Fortrea, and Amgen Shares Are Soaring, What You Need To Know

Bio-Techne, Tandem Diabetes, Align Technology, DexCom, and Teleflex Shares Skyrocket, What You Need To Know

JNJ

StockStory

16 days ago

Bio-Techne, Tandem Diabetes, Align Technology, DexCom, and Teleflex Shares Skyrocket, What You Need To Know

Pulmonary Arterial Hypertension Market Research Report 2025, Competitive Analysis of Gilead Sciences, Viatris, Sandoz, J&J, Sun Pharma, Lupin Pharma, GlaxoSmithKline, Bayer, United Therapeutics

JNJ

GlobeNewswire

16 days ago

Pulmonary Arterial Hypertension Market Research Report 2025, Competitive Analysis of Gilead Sciences, Viatris, Sandoz, J&J, Sun Pharma, Lupin Pharma, GlaxoSmithKline, Bayer, United Therapeutics

JNJ

Black Enterprise

17 days ago

Black Hair Accessories Brand Targets $50M Revenue By 2030 With New Products, Market Expansion

Jim Cramer Says Haleon’s “Stock’s Been Struggling”

JNJ

Insider Monkey

18 days ago

Jim Cramer Says Haleon’s “Stock’s Been Struggling”

Jim Cramer Says He “Believed in” Bristol-Myers’ Cobenfy But “It’s Not Selling Well at All”

JNJ

Insider Monkey

19 days ago

Jim Cramer Says He “Believed in” Bristol-Myers’ Cobenfy But “It’s Not Selling Well at All”

Will Recursion Pharmaceuticals’ (RXRX) New CEO Accelerate Its AI Ambitions and Strategic Partnerships?

JNJ

Simply Wall St.

20 days ago

Will Recursion Pharmaceuticals’ (RXRX) New CEO Accelerate Its AI Ambitions and Strategic Partnerships?

J&J’s Darzalex gains first FDA approval in smouldering multiple myeloma

JNJ

Pharmaceutical Technology

20 days ago

J&J’s Darzalex gains first FDA approval in smouldering multiple myeloma

Is a Market Correction Coming? Better Grab 5 of the Safest Dividend Kings Now

JNJ

24/7 Wall St.

20 days ago

Is a Market Correction Coming? Better Grab 5 of the Safest Dividend Kings Now

FDA Approved DARZALEX Faspro® for Adult Patients with High-Risk Smoldering Multiple Myeloma

JNJ

PR Newswire

20 days ago

FDA Approved DARZALEX Faspro® for Adult Patients with High-Risk Smoldering Multiple Myeloma

DARZALEX FASPRO® is the first and only treatment approved by the U.S. FDA for patients with high-risk smoldering multiple myeloma

JNJ

PR Newswire

20 days ago

DARZALEX FASPRO® is the first and only treatment approved by the U.S. FDA for patients with high-risk smoldering multiple myeloma

How Recent Developments Are Shaping the Johnson & Johnson Investment Story

JNJ

Simply Wall St.

21 days ago

How Recent Developments Are Shaping the Johnson & Johnson Investment Story

J&J’s Caplyta wins MDD approval to extend revenue horizon

JNJ

Pharmaceutical Technology

21 days ago

J&J’s Caplyta wins MDD approval to extend revenue horizon

JNJ

MT Newswires

21 days ago

Texas Attorney General Files Motion to Stop Kenvue From Paying November Dividends

Chronic Heart Failure Market Analysis and Forecast, 2025-2035, Featuring AstraZeneca, Bristol Myers Squibb, Cytokinetics, Bayer, Eli Lilly and Other Leading Players

JNJ

GlobeNewswire

21 days ago

Chronic Heart Failure Market Analysis and Forecast, 2025-2035, Featuring AstraZeneca, Bristol Myers Squibb, Cytokinetics, Bayer, Eli Lilly and Other Leading Players

AstraZeneca CEO bullish on record revenue numbers and US growth

JNJ

Yahoo Finance Video

21 days ago

AstraZeneca CEO bullish on record revenue numbers and US growth

FDA approval of CAPLYTA® (lumateperone) has the potential to reset treatment expectations, offering hope for remission in adults with major depressive disorder

JNJ

PR Newswire

21 days ago

FDA approval of CAPLYTA® (lumateperone) has the potential to reset treatment expectations, offering hope for remission in adults with major depressive disorder

Latest Johnson & Johnson (JNJ) News on November 27, 2025

Share on Social Networks: